Early Vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease

Luisa Guidi  1     Daniela Pugliese  1     Tommaso Panici Tonucci  1     Lorenzo Bertani  2     Francesco Costa     Giuseppe Privitera     Elisa Gremese     Barbara Tolusso     Clara Di Mario     Alfredo Papa     Antonio Gasbarrini     Gian Lodovico Rapaccini     Alessandro Armuzzi    
1 Fondazione Policlinico Universitario A. Gemelli IRCCS Università Cattolica del Sacro Cuore,Roma,Italy
2 University of Pisa,Pisa,Italy

Session
IBD II (Posters)

Conference
UEG Week 2019

Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing